Northern Trust Corp Raises Holdings in Apyx Medical Co. (NASDAQ:APYX)

Northern Trust Corp increased its stake in shares of Apyx Medical Co. (NASDAQ:APYX) by 27.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 132,251 shares of the company’s stock after acquiring an additional 28,865 shares during the quarter. Northern Trust Corp owned approximately 0.35% of Apyx Medical worth $209,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of APYX. Raymond James Financial Inc. purchased a new stake in shares of Apyx Medical during the fourth quarter valued at approximately $134,000. Kingsview Wealth Management LLC raised its holdings in Apyx Medical by 8.7% during the 4th quarter. Kingsview Wealth Management LLC now owns 135,245 shares of the company’s stock valued at $214,000 after buying an additional 10,800 shares during the last quarter. Geode Capital Management LLC boosted its position in Apyx Medical by 7.5% during the 4th quarter. Geode Capital Management LLC now owns 352,809 shares of the company’s stock valued at $558,000 after buying an additional 24,596 shares during the period. Commonwealth Equity Services LLC grew its holdings in Apyx Medical by 3.0% in the 4th quarter. Commonwealth Equity Services LLC now owns 527,061 shares of the company’s stock worth $833,000 after acquiring an additional 15,500 shares during the last quarter. Finally, Royce & Associates LP increased its position in shares of Apyx Medical by 1.3% in the fourth quarter. Royce & Associates LP now owns 2,615,369 shares of the company’s stock valued at $4,132,000 after acquiring an additional 32,879 shares during the period. 55.33% of the stock is currently owned by institutional investors.

Apyx Medical Stock Performance

Shares of NASDAQ:APYX opened at $1.62 on Tuesday. The company has a current ratio of 5.46, a quick ratio of 4.52 and a debt-to-equity ratio of 3.03. The company has a 50-day moving average price of $1.20 and a 200-day moving average price of $1.37. The company has a market cap of $61.23 million, a price-to-earnings ratio of -1.95 and a beta of 1.12. Apyx Medical Co. has a 12 month low of $0.76 and a 12 month high of $1.95.

Apyx Medical (NASDAQ:APYX) last announced its quarterly earnings results on Thursday, May 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.03. The company had revenue of $9.43 million for the quarter, compared to the consensus estimate of $9.39 million. Apyx Medical had a negative return on equity of 137.98% and a negative net margin of 58.59%. As a group, equities analysts anticipate that Apyx Medical Co. will post -0.68 EPS for the current year.

Apyx Medical Profile

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.